Interpace, Affirma, and Thyroseq Performance Characteristics in 341 Bethesda Category III/IV Thyroid Nodules

被引：0
|
作者：
Connelly, C. F. [1 ]
Cimic, A. [2 ]
Baskota, S. [2 ]
机构：
[1] Columbia Univ, Irving Med Ctr, New York Presbyterian, New York, NY USA
[2] Columbia Univ, Irving Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2023年 / 160卷
关键词：
D O I：
10.1093/ajcp/aqad150.051
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
aqad150.05
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [1] Interpace, Affirma, and Thyroseq Performance Characteristics in 341 Bethesda Category III/IV Thyroid Nodules
    Connelly, C. F.
    Cimic, A.
    Baskota, S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S23 - S24
  • [2] AI diagnosis of Bethesda category IV thyroid nodules
    Yao, Jincao
    Zhang, Yanming
    Shen, Jiafei
    Lei, Zhikai
    Xiong, Jing
    Feng, Bojian
    Li, Xiaoxian
    Li, Wei
    Ou, Di
    Lu, Yidan
    Feng, Na
    Yan, Meiying
    Chen, Jinjie
    Chen, Liyu
    Yang, Chen
    Wang, Lipin
    Wang, Kai
    Zhou, Jianhua
    Liang, Ping
    Xu, Dong
    ISCIENCE, 2023, 26 (11)
  • [3] Risk Stratification of Bethesda III Category Thyroid Nodules
    Alseddeeqi, Eiman
    Mubarak, Rawia
    Altinoz, Ajda
    More, Yogesh
    Elomami, Abdulghani
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 9 (06) : 180 - 185
  • [4] Misleading Clinical Significance of Bethesda Category IV for Thyroid Nodules
    Buonocore, Darren
    Lin, Oscar
    Cohen, Jean Marc
    LABORATORY INVESTIGATION, 2018, 98 : 135 - 135
  • [5] Misleading Clinical Significance of Bethesda Category IV for Thyroid Nodules
    Buonocore, Darren
    Lin, Oscar
    Cohen, Jean Marc
    MODERN PATHOLOGY, 2018, 31 : 135 - 135
  • [6] Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
    Liu, Xiaoli
    Wang, Jingjing
    Du, Wei
    Dai, Liyuan
    Fang, Qigen
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Evaluation of thyroid nodules classified as Bethesda category III on FNAC
    Garg, Shiwani
    Naik, Leena P.
    Kothari, Kanchan S.
    Fernandes, Gwendolyn C.
    Agnihotri, Mona A.
    Gokhale, Jagruti C.
    JOURNAL OF CYTOLOGY, 2017, 34 (01) : 5 - 9
  • [8] Improving Diagnostic Performance for Thyroid Nodules Classified as Bethesda Category III or IV: How and by Whom Ultrasonography Should be Performed
    Scerrino, Gregorio
    Cocorullo, Gianfranco
    Mazzola, Sergio
    Melfa, Giuseppina
    Orlando, Giuseppina
    Laise, Iole
    Corigliano, Alessandro
    Lo Brutto, Daniela
    Cipolla, Calogero
    Graceffa, Giuseppa
    JOURNAL OF SURGICAL RESEARCH, 2021, 262 : 203 - 211
  • [9] The role of active surveillance for Bethesda III/IV thyroid nodules and the differential risk associated with nuclear atypia in Bethesda III category cytology
    Collins, Jennifer
    Takhar, Arunjit
    Brunet, Aina
    Moonim, Mufaddal
    Gill-Barman, Baljit
    Chandra, Ashish
    Simo, Ricard
    Jeannon, Jean-Pierre
    ORAL ONCOLOGY, 2021, 118
  • [10] Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
    Turkdogan, Sena
    Pusztaszeri, Marc
    Forest, Veronique-Isabelle
    Hier, Michael P.
    Payne, Richard J.
    CANCERS, 2020, 12 (09) : 1 - 8
12345